Skip to content

Clinical trials

Shock, Cardiogenic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Cardiogenic Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20161
20171
20182
20191
20221
20233
20241
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10
Recruiting5
Not yet recruiting4
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital5
Nanjing Medical University3
Renmin Hospital of Wuhan University2
Shenzhen Core Medical Technology CO.,LTD.2
China National Center for Cardiovascular Diseases1
First Affiliated Hospital Xi'an Jiaotong University1
ForQaly Medical (Shanghai) Co., Ltd1
Fujian Medical University1
Qilu Hospital of Shandong University1
Second Affiliated Hospital of Guangzhou Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Cardiogenic20
Heart Arrest4
Heart Failure4
Respiratory Distress Syndrome2
Acute Coronary Syndrome1
Cardiac Output, Low1
Coronary Artery Disease1
Coronary Disease1
Heart Septal Defects, Ventricular1
Myocardial Infarction1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.